• Kenichi Matsuda, Takeshi Moriguchi, Norikazu Harii, Masahiko Yanagisawa, Daiki Harada, and Hisanori Sugawara.
• Department of Emergency and Critical Care Medicine, University of Yamanashi School of Medicine, Yamanashi, Japan. matsudak@yamanashi.ac.jp
• Contrib Nephrol. 2011 Jan 1;173:182-90.

AbstractThe aim of this study was to investigate whether continuous hemodiafiltration (CHDF) with a high-performance membrane dialyzer made of polymethylmethacrylate (PMMA-CHDF) in the treatment of septic shock patients with acute renal failure (ARF) is clinically relevant. 30 patients were treated with PMMA-CHDF. 13 patients treated with CHDF used a hemofilter made of polyacrylonitrile membrane (PAN-CHDF). Systolic blood pressure significantly increased in the PMMA-CHDF group following 24 h of treatment (p < 0.01), whereas it did not improve in the PAN-CHDF group. Urine volume significantly increased in the PMMA-CHDF group following 24 h of treatment which was more than in the PAN-CHDF group (p < 0.05). 28-day survival was 83.3% in the PMMA-CHDF group and 30.8% in the PAN-CHDF group, respectively (p < 0.01). We can assume that PMMA-CHDF in the treatment of septic shock patients with ARF is clinically relevant.Copyright © 2011 S. Karger AG, Basel.

40 keywords...

hide…